MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
July 18, 2023MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...
Read more
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
July 10, 2018Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes two patent oppositions filed by Delhi Network of Positive People (DNP+) before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir....
Read more
Indian patent office delivers major blow to affordable pneumonia vaccine hopes
August 22, 2017Geneva/New York/New Delhi, 22 August 2017 – Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia were dealt a major blow after the Indian patent office granted a patent to...
Read more
